162 related articles for article (PubMed ID: 7935334)
1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
Peng X; Gerzanich V; Anand R; Whiting PJ; Lindstrom J
Mol Pharmacol; 1994 Sep; 46(3):523-30. PubMed ID: 7935334
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
Bencherif M; Fowler K; Lukas RJ; Lippiello PM
J Pharmacol Exp Ther; 1995 Nov; 275(2):987-94. PubMed ID: 7473192
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.
Papke RL; Sanberg PR; Shytle RD
J Pharmacol Exp Ther; 2001 May; 297(2):646-56. PubMed ID: 11303054
[TBL] [Abstract][Full Text] [Related]
5. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
Pauly JR; Marks MJ; Robinson SF; van de Kamp JL; Collins AC
J Pharmacol Exp Ther; 1996 Jul; 278(1):361-9. PubMed ID: 8764371
[TBL] [Abstract][Full Text] [Related]
6. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
7. Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines.
Tumkosit P; Kuryatov A; Luo J; Lindstrom J
Mol Pharmacol; 2006 Oct; 70(4):1358-68. PubMed ID: 16835356
[TBL] [Abstract][Full Text] [Related]
8. Imidacloprid, thiacloprid, and their imine derivatives up-regulate the alpha 4 beta 2 nicotinic acetylcholine receptor in M10 cells.
Tomizawa M; Casida JE
Toxicol Appl Pharmacol; 2000 Nov; 169(1):114-20. PubMed ID: 11076703
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
10. Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
Pereira EF; Alkondon M; Reinhardt S; Maelicke A; Peng X; Lindstrom J; Whiting P; Albuquerque EX
J Pharmacol Exp Ther; 1994 Aug; 270(2):768-78. PubMed ID: 8071869
[TBL] [Abstract][Full Text] [Related]
11. Desensitized nicotinic receptors in brain.
Wang H; Sun X
Brain Res Brain Res Rev; 2005 Jun; 48(3):420-37. PubMed ID: 15914250
[TBL] [Abstract][Full Text] [Related]
12. Bupropion is a nicotinic antagonist.
Slemmer JE; Martin BR; Damaj MI
J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
[TBL] [Abstract][Full Text] [Related]
13. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
Gerzanich V; Anand R; Lindstrom J
Mol Pharmacol; 1994 Feb; 45(2):212-20. PubMed ID: 7509438
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
Marks MJ; Farnham DA; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Feb; 264(2):542-52. PubMed ID: 8437106
[TBL] [Abstract][Full Text] [Related]
15. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
16. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells.
Zia S; Ndoye A; Nguyen VT; Grando SA
Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):243-62. PubMed ID: 9387186
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
Ke L; Eisenhour CM; Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of nicotine-induced seizures in mice.
Damaj MI; Glassco W; Dukat M; Martin BR
J Pharmacol Exp Ther; 1999 Dec; 291(3):1284-91. PubMed ID: 10565853
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
ZieliĆska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]